Laurent-Puig P - Search Results

1

Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort.

Gorgeu V, Borghese B, Koual M, Just PA, Lefrere Belda MA, Delanoy N, Durdux C, Chapron C, Goldwasser F, Gervais C, Blons H, Terris B, Badoual C, Taly V, Laurent-Puig P, Bats AS, Alexandre J, Beinse G. Gorgeu V, et al. Gynecol Oncol. 2022 Aug;166(2):269-276. doi: 10.1016/j.ygyno.2022.05.016. Epub 2022 May 26. Gynecol Oncol. 2022. PMID: 35643579

2

Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France.

Terris B, Laurent-Puig P, Belghitti J, Degott C, Hénin D, Fléjou JF. Terris B, et al. Int J Cancer. 1997 Dec 19;74(6):614-9. doi: 10.1002/(sici)1097-0215(19971219)74:6<614::aid-ijc10>3.0.co;2-5. Int J Cancer. 1997. PMID: 9421358

3

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

Cabelguenne A, Blons H, de Waziers I, Carnot F, Houllier AM, Soussi T, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P. Cabelguenne A, et al. J Clin Oncol. 2000 Apr;18(7):1465-73. doi: 10.1200/JCO.2000.18.7.1465. J Clin Oncol. 2000. PMID: 10735894

4

Sequence of molecular genetic events in colorectal tumorigenesis.

Laurent-Puig P, Blons H, Cugnenc PH. Laurent-Puig P, et al. Eur J Cancer Prev. 1999 Dec;8 Suppl 1:S39-47. Eur J Cancer Prev. 1999. PMID: 10772417 Review.

5

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Lecomte T, Berger A, Zinzindohoué F, Micard S, Landi B, Blons H, Beaune P, Cugnenc PH, Laurent-Puig P. Lecomte T, et al. Int J Cancer. 2002 Aug 10;100(5):542-8. doi: 10.1002/ijc.10526. Int J Cancer. 2002. PMID: 12124803

6

TP53 and head and neck neoplasms.

Blons H, Laurent-Puig P. Blons H, et al. Hum Mutat. 2003 Mar;21(3):252-7. doi: 10.1002/humu.10171. Hum Mutat. 2003. PMID: 12619110 Review.

7

[Cellular and neoplastic otorhinolaryngologic changes, molecular markers and therapeutic potential].

Blons H, Laccourreye O, Laurent-Puig P. Blons H, et al. Ann Otolaryngol Chir Cervicofac. 2003 Jun;120(3):152-60. Ann Otolaryngol Chir Cervicofac. 2003. PMID: 12843984 Review. French.

8

Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P. Zinzindohoué F, et al. Anticancer Res. 2004 May-Jun;24(3b):2021-6. Anticancer Res. 2004. PMID: 15274394 Free article.

9

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P. Zinzindohoué F, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9. Clin Cancer Res. 2005. PMID: 15701845

10

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma.

Lièvre A, Blons H, Houllier AM, Laccourreye O, Brasnu D, Beaune P, Laurent-Puig P. Lièvre A, et al. Br J Cancer. 2006 Mar 13;94(5):692-7. doi: 10.1038/sj.bjc.6602993. Br J Cancer. 2006. PMID: 16495928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters